There’s a strong indication that Pfizer’s coronavirus vaccine may be the first to market. Just a week after announcing its vaccine is more than 90% effective, STAT News reports:
Pfizer may be within days of filing for an emergency use authorization for its Covid-19 vaccine, having collected the safety data necessary to submit an application to the Food and Drug Administration, CEO Albert Bourla said Tuesday.
“We are very close to submitting for an emergency use authorization,” Bourla said during the STAT Summit, which this year is a virtual event. Bourla sidestepped the question of whether Pfizer’s filing would be made this week.
*This is a developing story, check back for more